US News

Moderna begins human trial for multi-strain mRNA flu vaccine

Published by
AFP

Washington (AFP) – US biotech firm Moderna said Wednesday it had dosed its first participants in a human study of an mRNA vaccine that targets multiple strains of influenza. The company intends to recruit 180 adults in the United States for the Phase 1/2 portion of the trial to evaluate the safety and strength of immune response to the shot, called mRNA-1010. It is based on the same messenger ribonucleic (mRNA) technology deployed in Moderna’s Covid-19 shot, which is more than 90 percent effective, and if the trial proves successful, it could lead to a new generation of more protective flu vac…

Read More

Facebook Comments

Check Also

Israel Blamed For Fresh Airstrikes Deep Inside Iraq

Israel Blamed For Fresh Airstrikes Deep Inside Iraq ...

Archives